Bio-data of


Sharma RK. Field-evaluation of 3 repellents against mosquitos, black flies and land leeches. Indian Journal of Medical Research



Yüklə 1,05 Mb.
səhifə10/17
tarix27.10.2017
ölçüsü1,05 Mb.
#15608
1   ...   6   7   8   9   10   11   12   13   ...   17
Sharma RK. Field-evaluation of 3 repellents against mosquitos, black flies and land leeches. Indian Journal of Medical Research 80 (Nov): 541-545 (1984)




3.1

Deb U, Ahmed F, Singh S, Mendki MJ, Vijayaraghavan R. Comparative effects of insect repellent N,N-diethylbenzamide, N,N-diethylphenylacetamide, and N,N-diethyl-3- methylbenzamide aerosols on the breathing pattern and respiratory variables in mice. Inhal Toxicol. 2010 22;(6):469-78.




3.2

T. J. Naucke, R. Kröpke, G. Benner, J. Schulz, K. P. Wittern, A. Rose, U. Kröckel H. W. Grünewald. Field evaluation of the efficacy of proprietary repellent formulations with IR3535® and Picaridin against Aedes aegypti. Parasitology Research, 101(1), 169-177, 2007




3.3

Dana Chaiyasit,Wej Choochote,Eumporn Rattanachanpichai, Udom Chaithong1,Prasong Chaiwong1,Atchariya Jitpakdi1,Pongsri Tippawangkosol1,Doungrat Riyong1 and Benjawan Pitasawat1. Essential oils as potential adulticides against two populations of Aedes aegypti, the laboratory and natural field strains, in Chiang Mai province, northern Thailand. Parasitology Research, 99(6), 715-721, 2007




3.4

Taisya D. Chermenskaya a;  Maria O. Petrova a; Elena I. Savelieva. Laboratory and field evaluation of biological active substances of plant origin against greenhouse whitefly, Trialeurodes vaporariorum Westw. (Homoptera: Aleyrodidae). Archives Of Phytopathology And Plant Protection DOI: 10.1080/03235400701494422




3.5

Kalyanasundaram M, Mathew N. N, N-Diethyl Phenylacetamide (DEPA): A Safe and Effective Repellent for Personal Protection Against Hematophagous Arthropods. Journal of Medical Entomology: Vol. 43, No. 3 pp. 518–525(2006)




3.6

D Strickman. Older Synthetic Active Ingredients and Current Additives.
In: Insect Repellents Principles, Methods, and Uses (Eds Mustapha Debboun, Stephen P Frances, Daniel Strickman), CRC Press, Taylor & Francis Group, Boca Raton , Flourida (2006)




3.7

S Prakash, R Vijayaraghavan, K Sekhar. DEPA: Efficacy, Safety, and Use of N, N-Diethyl Phenylacetamide, a Multi-Insect Repellent
In: Insect Repellents Principles, Methods, and Uses (Eds Mustapha Debboun, Stephen P Frances, Daniel Strickman), CRC Press, Taylor & Francis Group, Boca Raton , Flourida (2006)




3.8

Moore, S.J. and Debboun, M.The History of Insect Repellents. In: Insect Repellents Principles, Methods, and Uses (Eds Mustapha Debboun, Stephen P Frances, Daniel Strickman), CRC Press, Taylor & Francis Group, Boca Raton , Flourida (2006)




3.9

Nath DR, Das NG, Das, S.C. Bio-repellents for land leeches Defence Science Journal 52 (1), pp. 73-76, (2002)




3.10

Sadanandanc C, Mathew N, Jambulingam P. Laboratory & field evaluation of controlled release formulation of the insect repellents N,N-diethyl-m-toluamide (DEET) & N,N-diethyl phenylacetamide (DEPA) against mosquito vectors. Indian J Med Res 113: 108-112 (2001)




3.11

Das NG, Nath DR, Baruah I, Talukdar PK, Das SC. Field evaluation of herbal mosquito repellents. Journal of Communicable Diseases 31 (4), 241-245 ,(1999)




3.12

Sridharan TB, Prakash S, Chauhan RS. Sensilla on the palps and legs of the adult soft tick Argas persicus Oken (Izodoidea : Argasidae) and their projections to the central nervous system. Int J Insect Morphol and Embryology 27 (4): 273-289 (1998)




3.13

Prakash S, Chauhan RS, Parashar BD. Morphology and distribution of antennal sensilla in the postembryonic developmental stages of Cimex hemipterus Fabricius. Ital J Zool 63 (2): 131-134 (1996)




3.14

Kumar S, Prakash S, Rao KM. Comparative activity of 3 repellents against bedbugs cimex-hemipterus (FABR). Indian J Med Res 102: 20-23 (1995)




3.15

Sikdar N, Gopalan N, Prakash S. Mosquito repellency and toxicity of isomeric N,N-diethyltolylacetamides. Indian J Med Res 99: 121-123 (1994)




3.16

Kalyanasundaram M, Srinivasan R, Subramanian S. Relative potency of depa as a repellent against the sandfly phlebotomus-papatasi. Med Vet Entomol 8 (1):68-70 (1994)




3.17

Parashar BD, Gupta GP, Sikder N. Diethylphenylacetamide - a new insect repellent against stable fly, stomoxys-calcitrans. Med. Vet. Entomol 7 (3): 259-262 (1993)




3.18

Nath DR, Das NG, Das SC. Persistence of leech repellents on cloth. Indian J Med Res-A 97: 128-131 (1993)




3.19

Combemale P, Deruaz D, Villanova D. Repellents. Ann Dermatol vener 119 (5): 411-434 (1992)




3.20

Suryanarayana MVS, Pandey KS, Prakash S. Structure activity relationship studies with mosquito repellent amides. J Pharm Sci 80 (11): 1055-1057 (1991)




3.21

Prakash S, Selvamurthy W, Rao KM. Invivo experimental-model to evaluate the insect repellent N-N, diethylphenylacetamide in periplaneta-americana linn. Indian J Med Res-A 93: 182-188 (1991)




3.22

Rao SS, Rao KM. Insect repellent N,N-Diethylphenylacetamide - An update. J Med Entomol 28 (3): 303-306 (1991)




3.23

Vijayaraghavan R, Rao SS, Suryanarayana MVS. Acute and subacute inhalation toxicity studies of a new broad-spectrum insect repellent, N,N-Diethylphenylacetamide. Toxicology 67 (1): 85-96 (1991)




3.24

Rao SS, Jaiswal DK, Ramachandran PK. Distribution and metabolism of insect repellent N,N-diethylphenylacetamide on oral-exposure in rats. Toxicol lett 55 (3): 243-248 (1991)




3.25

Rao KM, Prakash S, Kumar S. N,N-Diethylphenylacetamide in treated fabrics as a repellent against aedes-aegypti and culex-quinquefasciatus (Diptera, culicidae). J Med Entomol 28 (1): 142-146 (1991)



3.26

Prasad MP, Kalyanasundaram M. Development and evaluation of controlled release formulations of DEPA, an insect repellent. Indian J Med Res-A 91: 453-457 (1990)




3.27

Prakash S, Srivastava CP, Kumar S. N,N-diethylphenylacetamide - a new repellent for periplaneta-americana (dictyoptera, blattidae), blattella-germanica, and supella longipalpa (dictyoptera, blattellidae). J Med Entomol 27 (6):962-967 (1990)




3.28

Rao SS, Swamy RV, Ramachandran PK. Toxicity and metabolism of a new insect repellent N,N-diethylphenylacetamide in mice, rats and guinea-pigs on cutaneous application. Toxicology 58 (1): 81-89 (1989)




3.29

Rao SS, Vijayaraghavan R, Suryanarayana MVS. Gas-chromatographic identification of urinary metabolites of insect repellent N,N-diethylphenylacetamide on inhalation exposure in rats. J Chromatogr-Biomed 493 (1): 210-216 (1989)




3.30

Rao SS, Rao KM, Ramachandran PK. Chemistry, efficacy and toxicology of insect repellents. J Sci Ind Res India 47 (12): 722-735 (1988)




3.31

Rao SS, Agarwal MK, Rao KM. Study on dermal toxicity and urinary metabolites of the new insect repellent N,N-Diethylphenyl-acetamide in rabbits. Toxicol Lett 45 (1): 67-72 (1989)




3.32

Meshram GP, Rao KM. N,N-Diethylphenylacetamide, an insect repellent absence of mutagenic response in the invitro ames test and invivo mouse micronucleus test. Food Chem Toxicol 26(9): 791-796 (1988).




3.33

Rao SS, Prakash S, Rao KM. Blood Biochemical-changes induced by insect repellent. Indian J. Med. Res. 88: 76-84 (1988).




3.34

Prakash S, Kumar S. Suryanarayana MVS. Effectiveness of Macrogol and Talcum base formulations of a new insect repellent N,N-Diethylphenyl-acetamide. Int. J. Cosmetic Sci 10(1): 23-28 (1988).




3.35

Das SC, Bhuyan M, Chakraborty BC. Field trials on the relative efficacy of 3 repellents against mansonia mosquitos. Indian J. Med Res. 87: 176-1178 (1988).




3.36

Rao SS, Prakash S, Kumar S. Toxicologic studies of an insect repellent N,N-Diethylphenylacetamide




3.37

Kalyanasundaram M, Amalraj D, Paily KP. Synthesis of substituted amides for repellency against mosquitos. Curr Sci India 55 (5): 266-268 (1986).




3.38

Malhotra PR, Sarkar PK, Bhuyan M. Relative effectiveness of 4 commercial repellents against simuliids. Curr Sci India 55 (3): 142-142 (1986).




3.39

Das SC, Bhuyan M, Das NG. Field trials on the relative efficacy of 5 repellents against Simulium-Himalayense (Diptera, Simuliidae). Indian J. Med Res 81: 378-381 (1985).

4

Harivardhan Reddy L, Sharma RK, Chuttani K, Mishra AK, Murthy RSR. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice Journal of Controlled Release, 105 (3), pp. 185-198 (2005)




4.1

Pavan P,Adiseshaiah, Jennifer B, Hall, Scott E. McNeil. Nanomaterial standards for efficacy and toxicity assessment. WREs Nanomedicine and Nanobiotechnology ( DOI: 10.1002/wnan.66)







Upadhyay KK, Bhatt AN, Castro E, Mishra AK, Chuttani K, Dwarakanath BS, Schatz C, Le Meins JF, Misra A, Lecommandoux S. Macromol. Biosci. 5/2010. Macromol Biosci. 2010 20;10(5): 503-12.







Mondal N, Halder KK, Kamila MM, Debnath MC, Pal TK, Ghosal SK, Sarkar BR, Ganguly S. Preparation, characterization, and biodistribution of letrozole loaded PLGA nanoparticles in Ehrlich Ascites tumor bearing mice. Int J Pharm. 2010 397(1-2):194-200.




4.2

Helbok A, Decristoforo C, Dobrozemsky G, Rangger C, Dierderen E, Stark B, Prassi R, Guggenberg EV. Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison with different radiometals. Journal of Liposomal Research (Posted online on 28th Oct 2009)




4.3

Jabbari E. Targeted delivery with peptidomimetic conjugated self-assembled nanoparticles Pharmaceutical Research 26 (3), pp. 612-630 (2009)




4.4

Sharma P, Ganta S, Denny WA, Garg S. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil International Journal of Pharmaceutics 367 (1-2), pp. 187-194 (2009)




4.5

Joshi MD, Müller RH. Lipid nanoparticles for parenteral delivery of actives European Journal of Pharmaceutics and Biopharmaceutics 71 (2), pp. 161-172 (2009)




4.6

Chattopadhyay N, Zastre J, Wong H-L, Wu XY, Bendayan R. Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line Pharmaceutical Research 25 (10), pp. 2262-2271 (2008)




4.7

Yadav AK, Mishra P, Jain S, Mishra P, Mishra AK, Agrawal GP. Preparation and characterization of HA-PEG-PCL intelligent core corona nanoparticles for delivery of doxorubicin Journal of Drug Targeting 16 (6), pp. 464-478 (2008)




4.8

Halder KK, Mandal B, Debnath MC, Bera H, Ghosh LK, Gupta BK. Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: Formulation, characterization, technetium-99m labeling and biodistribution studies Journal of Drug Targeting 16 (4), pp. 311-320 (2008)




4.9

Garg M, Garg BR, Jain S, Mishra P, Sharma RK, Mishra AK, Dutta T, Jain NK. Radiolabeling, pharmacoscintigraphic evaluation and antiretroviral efficacy of stavudine loaded 99mTc labeled galactosylated liposomes European Journal of Pharmaceutical Sciences 33 (3), pp. 271-281(2008)




4.10

Rai S, Paliwal R, Gupta PN, Khatri K, Goyal AK, Vaidya B, Vyas SP. Solid lipid nanoparticles (SLNs) as a rising tool in drug delivery science: One step up in nanotechnology Current Nanoscience 4 (1), pp. 30-44(2008)




4.11

Bešić E. Physical mechanisms and methods employed in drug delivery to tumors Acta Pharmaceutica 57 (3), pp. 249-268 (2007)




4.12

Pope-Harman A, Cheng MM-C, Robertson F, Sakamoto J, Ferrari M. Biomedical Nanotechnology for Cancer Medical Clinics of North America 91 (5), pp. 899-927 (2007)




4.13

Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid nanoparticles for targeted brain drug delivery Advanced Drug Delivery Reviews 59 (6), pp. 454-477(2007)




4.14

Wong HL, Bendayan R, Rauth AM, Li Y, Wu XY. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles Advanced Drug Delivery Reviews 59 (6), pp. 491-504 (2007)




4.15

Tian L, He H, Tang X. Stability and degradation kinetics of etoposide-loaded parenteral lipid emulsion Journal of Pharmaceutical Sciences 96 (7), pp. 1719-1728 (2007)




4.16

Agashe HB, Babbar AK, Jain S, Sharma RK, Mishra AK, Asthana A, Garg M, (...), Jain NK. Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers Nanomedicine: Nanotechnology, Biology, and Medicine 3 (2), pp. 120-127(2007)




4.17

Tao X, Chen H, Sun X-J, Chen J-F, Roa WH. Formulation and cytotoxicity of doxorubicin loaded in self-assembled bio-polyelectrolyte microshells International Journal of Pharmaceutics 336 (2), pp. 376-381(2007)




4.18

Murthy RSR, Shah NM. Strategies for inhibition of P-glycoproteins for effective treatment of multidrug resistance tumors Journal of Biomedical Nanotechnology 3 (1), pp. 1-17(2007)




4.19

Wong HL, Rauth AM, Bendayan R, Wu XY. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model European Journal of Pharmaceutics and Biopharmaceutics 65 (3), pp. 300-308 (2007)




4.20

Lo C-L, Huang C-K, Lin K-M, Hsiue G-H. Mixed micelles formed from graft and diblock copolymers for application in intracellular drug delivery Biomaterials 28 (6), pp. 1225-1235 (2007)




4.21

Chavanpatil MD, Khdair A, Panyam J. Nanoparticles for cellular drug delivery: Mechanisms and factors influencing delivery Journal of Nanoscience and Nanotechnology 6 (9-10), pp. 2651-2663 (2006)




4.22

Harivardhan Reddy L, Vivek K, Bakshi N, Murthy RSR. Tamoxifen citrate loaded solid lipid nanoparticles (SLN™): Preparation, characterization, in vitro drug release, and pharmacokinetic evaluation Pharmaceutical Development and Technology 11 (2), pp. 167-177 (2006)




4.23

Zhang Z, Bian H, Feng Q, Mi L, Mo T, Kuang A, Tan T, (...), Zhu, P. Biodistribution and localization of iodine-131-labeled Metuximab in patients with hepatocellular carcinoma Cancer Biology and Therapy 5 (3), pp. 318-322 (2006)




4.24

Reddy LH. Drug delivery to tumours: Recent strategies Journal of Pharmacy and Pharmacology 57 (10), pp. 1231-1242 (2005)

5.0

Jindal DP, Yadav MR, Sharma RK. Steroids and related studies .79. pregnano [3,4-CIS]-1',2',5'- oxadiazol-20-ones. Indian J of Chem Section B-organic Chemistry Including Medicinal Chemistry 26 (2): 100-103 (1987)




5.1

Pathak D, Jindal DP. Synthesis and anti-inflammatory activity of steroidal. Asian J Chem 10 (4): 813-817 (1998)




5.2

Jindal DP, Pathak D. Synthesis, anticancer and anti-HIV activities of some nitrogen mustard type nucleoazasteroids. Asian J Chem 10 (3): 563-566 (1998)




5.3

Verma AK, Gupta R, Yadav MR. Synthesis and biological-activity of steroidal [3,4-D] triazoles. Indian J Chem B 34 (3): 215-220 (1995)




5.3

Jindal DP, Gupta R, Abraham J. Synthesis and biological-activity of 17A-Azasteroidal [3,4-D] triazole. Indian J Chem B 33 (5): 499-501 (1994)




5.4

Pradhan BP, Ghosh P. Studies on reactions of 2-bromo-3-ketotriterpenoids .I. preparation of 2,3-dioximinotriterpenoid and subsequent cyclization of the dioximino derivative to [2,3-C]-1',2',5'-oxadiazole derivative and a new route to diosphenol synthesis. Indian J Chem B 32 (9): 920-923 (1993)




5.4

Jindal DP, Abraham J, yadav MR. Studies in 17A-azasteroidal [3,2-C] furoxans. Indian J Chem B 31 (10): 664-666 1992




5.5

Maes D, Wyns L, Lisgarten J. Structure of (20R)-5-alpha-pregnano [3,4-C] [1,2,5] oxadiazol-20-OL (HS 1011). Acta Crystallogr C 48: 1092-1095 part 6 (1992)




5.6

Jindal DP, Pathak D. Synthesis and antinflammatory activity of 2'-phenyl steroidal [17, 16-C] pyrazoles. Eur J Med Chem 26 (6): 651-654 (1991)




5.7

Yadav MR, Jindal DP. Certain steroidal (3,4-C)-1',2',5'-oxadiazoles. Indian J Chem B 30 (5): 473-476 (1991)




5.8

Turner AB. Steroids-reactions and partial syntheses. Nat Prod Rep 6 (6): 539-575 (1989)




5.9

Yadav MR, Abraham J, Jindal DP. Studies in steroidal [3, 4-C]-1', 2', 5’-oxadiazoles. Indian J Chem B 29 (1):26-28 (1990)




5.10

Yadav MR, Jindal DP. Singh H. Steroids in steroidal [3, 4-C]-1’, 2, 5’- oxadiazoles. Indian J Chem B 27 (3): 205-208 (1988)

6

Thakkar H, Sharma RK, Mishra AK, Chuttani K, Murthy RSR. Efficacy of chitosan microspheres for controlled intra-articular delivery of celecoxib in inflamed joints. Journal of Pharmacy and Pharmacology, 56 (9), pp. 1091-1099., (2004)




6.1

Mansour HM. Int J Mol Sci 2010. 11(9) 3298-3322




6.2

Nicoleta Butoescu, Olivier Jordan, Pierre Burdet, Pierre Stadelmann, Alke Petri-Fink, Heinrich Hofmann and Eric Doelker. Dexamethasone-containing biodegradable superparamagnetic microparticles for intra-articular administration: Physicochemical and magnetic properties, in vitro and in vivo drug release. European Journal of Pharmaceutics and Biopharmaceutics 72; 529-538 (2009).




6.3

Hetal Paresh Thakkar, Rayasa Ramachandra Murthy. Effect of cross-linking agent on the characteristics of celecoxib loaded chitosan microspheres. Asian J Pharmaceutics 2; 246-251 (2009).




6.4

N. Butoescu, O. Jordan and E. Doelker. Intra-articular drug delivery systems for the treatment of rheumatic diseases: A review of the factors influencing their performance. European Journal of Pharmaceutics and Biopharmaceutics 73; 205-218 (2009).




6.5

Mohammed F. Shamji, Priscilla Hwang, Robert W. Bullock, Samuel B. Adams, Dana L. Nettles, Lori A. Release and activity of anti-TNF therapeutics from injectable chitosan preparations for local drug delivery. Journal of Biomedical Materials Research Part B: Applied Biomaterials 90B; 319-326.




6.6

Burt Hm, Tsalias A, Glichrist S, Liang LS. Intra-articular drug delivery systems: overcoming the shortcomings of joint disease therapy. Expert Opinion on Drug Delivery 6: 17-26 (2009).




6.7

Mountziaris PM, Kramer PR, Mikos AG. Emerging intra-articular drug delivery systems for the temporomandibular joint Methods 47 (2), pp. 134-140 (2009)




6.8

Aly MNS. Intra-articular drug delivery: A fast growing approach Methods 47 (2), pp. 134-140 (2008)




6.9

Larsen C, Østergaard J, Larsen SW, Jensen H, Jacobsen S, Lindegaard C, Andersen PH. Intra-articular depot formulation principles: Role in the management of postoperative pain and arthritic disorders Journal of Pharmaceutical Sciences 97 (11), pp. 4622-4654 (2008)




6.10

Yadav AK, Mishra P, Jain S, Mishra P, Mishra AK, Agrawal GP. Preparation and characterization of HA-PEG-PCL intelligent core corona nanoparticles for delivery of doxorubicin Journal of Drug Targeting 16 (6), pp. 464-478 (2008)




6.11

Xiao W-J, Fan G-Y. Homologous chondrocytes in combination with chitosan to repair articular cartilage defects Journal of Clinical Rehabilitative Tissue Engineering Research 12 (19), pp. 3633- (2008)




6.12

Garg M, Garg B.R, Jain S, Mishra P, Sharma RK, Mishra AK, Dutta T, Jain NK. Radiolabeling, pharmacoscintigraphic evaluation and antiretroviral efficacy of stavudine loaded 99mTc labeled galactosylated liposomes European Journal of Pharmaceutical Sciences 33 (3), pp. 271-281(2008)




6.13

Guindon J, Walczak J-S, Beaulieu P. Recent advances in the pharmacological management of pain Drugs 67 (15), pp. 2121-2133 (2007)




6.14

Pavinatto FJ, Caseli L, Pavinatto A, Dos Santos Jr, DS, Nobre TM, Zaniquelli MED, Silva HS, (...), De Oliveira Jr, ON. Probing chitosan and phospholipid interactions using langmuir and langmuir-blodgett films as cell membrane models Langmuir 23 (14), pp. 7666-7671 (2007)




6.15

Bansal SS, Joshi A, Bansal AK. New dosage formulations for targeted delivery of cyclo-oxygenase-2 inhibitors: Focus on use in the elderly Drugs and Aging 24 (6), pp. 441-451 (2007)




6.16

Agashe HB, Babbar AK, Jain S, Sharma RK, Mishra AK, Asthana A, Garg M, (...), Jain NK. Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers Nanomedicine: Nanotechnology, Biology, and Medicine 3 (2), pp. 120-127 (2007)




6.17

Ruel-Gariépy E, Leroux J-C. Chitosan: A natural polycation with multiple applications ACS Symposium Series 934, pp. 243-259 (2006)

7.0

Effectiveness of Macrogol and Talcum Base formulations of a new insect repellent N,N-Diethyl Phenylacetamide. Prakash S, Kumar S, Suryanarayana MVS. International Journal of Cosmetic Science. 10)1): 23-28 (1988)




7.1

Gupta DC, Sumana G, Prakash S. Polysiloxane based slow release formulations of N, N-diethylphenylacetamide - a broad spectrum insect repellent. J Polym Mater 17(2): 215-219 (2000)




7.2

Suryanarayana MVS, Pandey KS, Prakash S. Structure activity relationship studies with Mosquito repellent amides. J Pharm Sci 80 (11): 1055-1057 (1991)




7.3

Prakash s. Selvamurthy W, Rao KM. In Vivo experimental model to evaluate the insect repellent N-N, diethyphenylacetamide in periplanetra americanalinn. Indian J Med Res-A 93: 182-1188 (1991)




7.4

Rao SS, Rao KM. Insect Repellent N, N-Diethylphenylacetamide - An update. J Med Entomol 28(3): 303-306 (1991)




7.5

Vijayaraghavan R, Rao SS, Suryanarayana MVS. Acute and Subacute inhalation Toxicity studies of a new broad-spectrum insect repellent. N, N-Diethylphenylacetamide. Toxicology 67 (1): 85-96 (1991)




7.6

Rao SS, Jaiswal DK, Ramachandran P.K. Distribution and Metabolism of insect repellent N, N-Diethylphenylacetamide on oral exposure in rats. Toxicol Lett 55 (3): 243-248 (1991)




7.7

Rao KM, Prakash S, Kumar S. N, N-Diethylphenylacetamide in treated fabrics as a repellent against aedes-aegypti and culex-Quinouefasciatus (Diptera, Culicidae). J. Med Entomol 28(1): 142-146 (1991)




7.8

Rao SS, Swamy RV, Ramachandran PK. Toxicity and Metabolism of a New insect repellent N, N-Diethylphenylacetamide in mice, rats and guinea - pigs on cutaneous applications. Toxicology 58 (1): 81-89 (1989)




7.9

Rao SS, Vijayaraghavan R, Suryanarayana MVS. Gas-Chromatographic identification of Urinary metabolites of insect repellent N, N-Diethylphenylacetamide on inhalation exposure in rats J Chromatogr-Biomed 493 (1): 210-216 (1989)




7.10

Rao SS, Rao KM, Ramachandran PK. Chemistry, Efficacy and Toxicology of Insect Repellents J Sci Ind Res India 47 (12): 722-735 (1988)




7.11

Rao SS, Afgrawal MK, Roa KM. Study on dermal toxicity and urinary metabolites of the new insect repellent N,N- Diethylphenyl-acetamide in rabbits. Toxicol lett 45 (1): 67-72 (1989)

8

Vyas TK, Babbar AK, Sharma RK, Singh S, Misra A. Intranasal mucoadhesive microemulsions of clonazepam: Preliminary studies on brain targeting. Journal of Pharmaceutical Sciences, 95 (3), pp. 570-580 (2006)




8.1

Sakata O, Onishi H, Machida Y. Development of semisolid dosage form of clonazepam for oral cavity administration]. Yakugaku Zasshi. 2010 130(1):119-25.




8.2

Khan S, Elshaer A, Rahman AS, Hanson P, Perrie Y, Mohammed AR. Genomic evaluation during permeability of indomethacin and its solid dispersion. J Drug Target. 2010 Nov 16. PMID: 21080758





8.3

Dhuria SV, Hanson LR, Frey WH 2nd. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010 99(4):1654-73.





8.4

Ali J, Ali M, Baboota S, Sahani JK, Ramassamy C, Dao L, Bhavna. Potential of nanoparticulate drug delivery systems by intranasal administration. Curr Pharm Des. 2010 16(14):1644-53.




8.5

Patel RB, Patel MR, Bhatt KK, Patel BG. Development and validation of an HPTLC method for determination of olanzapine in formulations. J AOAC Int. 2010 93(3):811-9.




8.6

Shahiwala, Aliasgar; Dash, Dilip. Advanced Science Letters. American Scientific Publishers. 2010 3(4): 442-446(5). DOI: 10.1166/asl.2010.1149




8.7

Pathan SA, Jain GK, Akhter S, Vohora D, Ahmad FJ, Khar RK. Insights into the novel three 'D's of epilepsy treatment: drugs, delivery systems and devices. Drug Discov Today. 2010. 15(17-18):717-32.




8.8

Lee KR, Maeng HJ, Chae JB, Chong S, Kim DD, Shim CK, Chung SJ. Lack of a primary physicochemical determinant in the direct transport of drugs to the brain after nasal administration in rats: potential involvement of transporters in the pathway. Drug Metab Pharmacokinet. 2010;25(5):430-41.




8.11

Rashmin B. Patel, Mrunali R. Patel, Kashyap K. Bhatt, and Bharat G. Patel. Development and Validation of HPTLC Method for Estimation of Carbamazepine in Formulations and Its In Vitro Release Study. Chromatography Research International Volume 2011 (2011), Article ID 684369, 8 pages doi:10.4061/2011/684369




8.12

Azeem, Adnan; Rizwan, Mohammad; Ahmad, Farhan J.; Khar, Roop K.; Iqbal, Zeenat; Talegaonkar, Sushama. Components Screening and Influence of Surfactant and Cosurfactant on Nanoemulsion Formation. Current Nanoscience, 5: 220-226 (2009).




8.13

Patel RB. Acta Chromatogr. 2010. 549: 549




8.14

Sheetal Porecha, Tapan shah, Viral Jogani, Sachin Naik, Ambikanandan Misra. Microemulsion based intranasal delivery system for treatment of insomnia. Drug Delivery 16; 128-134 (2009).  




8.15

Amrish Kumar, Pankaj Sharma, Ashwani Chaturvedi, Durga Jaiswal, Meenakshi Bajpai, Mukesh Choudhary, Indranil Kumar Yadav, Hari Pratap Singh,Dinesh Chandra and D.A. Jain. Formulation Devleopment of Sertraline Hydrochloride Microemulsion for intranasal delivery. Int J Chemtech Res 1; 941-947 (2009)




8.16

J Shaji, A Poddar, S Iyer Brain-targeted nasal clonazepam microspheres. Ind J Pharmceutical Sc 71; 715-718 (2009).




8.17

Ratnesh Jain, Swapna Nabar, Prajakta Dandekar and Vandana Patravale. Micellar Nanocarriers: Potential Nose-to-Brain Delivery of Zolmitriptan as Novel Migraine Therapy. Pharmaceutical Research 27; 655-664 (2010).




8.18

Hsing-Wen Sung et al. Nanoparticles for protein drug delivery. US patent no. 7611690. (Issue Date : 3 Nov 2009).




8.19

Rashmin B. Patel, Mrunali R. Patel, Kashyap K. Bhatt and Bharat G. Patel. HPTLC method development and validation: Quantification of paliperidone in formulations and in vitro release study. Analytical Methods 2010 (DOI: 10.1039/b9ay00276f).




8.20

Mao S, Cun Dongmei, Kawashima Y. Novel non-injectable formulation approaches of peptides and proteins. Delivery Technologies for Biopharmaceuticals : Peptides, Proteins, Nucleic Acid and Vaccines by Lene Jorgenson, Hanne Morck Nielson (2010).




8.21

Shagufta Khan‌, Kundan Patil‌, Nishan Bobade‌, Pramod Yeole‌, Rajiv Gaikwad‌. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats. J. Drug Targetting 18: 223- 234 (2010).




8.22

Shaji Jessy, Poddar Aditi. Intranasal Clonazepam Mucoadhesive Microspheres: Factorial Designing and Primary Evaluation. intranasal clonazepam (September 2009; http://priory.com/pharmacy/clonazepam.htm




8.23

Shyeilla V. Dhuria, Leah R. Hanson, William H. Frey II. Intranasal delivery to the central nervous system: Mechanisms and experimental considerations. Journal of Pharmaceutical Sciences 99; 1654-1673 (2009).




8.24

J. Yao, L. Hou, J. P. Zhou, Z. Q. Zhang and L. Sun. Preparation of lorazepam-loaded microemulsions for intranasal delivery and its pharmacokinetics. Pharmazie 64; 642-647




8.25

Mukesh Kumar, Kamla Pathak, Ambikanandan Misra. Formulation and Characterization of Nanoemulsion-Based Drug Delivery System of Risperidone. Drug Development and Industrial Pharmacy 35; 387 – 395 (2009).




8.26

Adnan Azeem, Mohammad Rizwan, Farhan J. Ahmad, Zeenat Iqbal, Roop K. Khar, M. Aqil and Sushama Talegaonkar. Nanoemulsion Components Screening and Selection: a Technical Note. AAPS PharmSciTech 10; 69-76 (2009).




8.27

Sakata O, Onishi H, Machida Y. Clonazepam oral droplets for the treatment of acute epileptic seizures Drug Development and Industrial Pharmacy 34 (12), pp. 1376-1380 (2008)




8.28

Talegaonkar S, Azeem A, Ahmad FJ, Khar RK, Pathan SA, Khan ZI Microemulsions: A novel approach to enhanced drug delivery Recent Patents on Drug Delivery and Formulation 2 (3), pp. 238-257 (2008)




8.29

Kumar M, Misra A, Mishra AK, Mishra P Pushpa, Pathak K. Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting Journal of Drug Targeting 16 (10), pp. 806-814; (2008)




8.29

Hervé K, Douziech-Eyrolles L, Munnier E, Cohen-Jonathan S, Soucé M, Marchais H, Limelette P., (...), Chourpa I. The development of stable aqueous suspensions of PEGylated SPIONs for biomedical applications Nanotechnology 19 (46), art. no. 465608 (2008)




8.30

DiNunzio JC, Williams III, RO. CNS disorders - Current treatment options and the prospects for advanced therapies Drug Development and Industrial Pharmacy 34 (11), pp. 1141-1167 (2008)




8.31

Gupta S, Moulik SP. Biocompatible microemulsions and their prospective uses in drug delivery Journal of Pharmaceutical Sciences 97 (1), pp. 22-45 (2008)




8.32

Kumar M, Misra A, Babbar AK, Mishra AK, Mishra P, Pathak K. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone International Journal of Pharmaceutics 358 (1-2), pp. 285-291 (2008)




8.33

Jogani VV, Shah PJ, Mishra P, Mishra AK, Misra AR. Nose-to-brain delivery of tacrine Journal of Pharmacy and Pharmacology 59 (9), pp. 1199-1205 (2007)




8.34

Charlton ST, Davis SS, Illum L. Nasal administration of an angiotensin antagonist in the rat model: Effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems International Journal of Pharmaceutics 338 (1-2), pp. 94-103 (2007)




8.35

Y. Kuramochi, T. Morita. Anticonvulsants for protracted seizures in children. The Lancet, 368; 576-576 (2006)

9.0

Tushar K. Vyas, A. K. Babbar, R. K. Sharma, Shashi Singh, Ambikanandan Misra (2006). Preliminary Brain Targeting Studies on Intranasal Mucoadhesive Microemulsions of Sumatriptan. PharmSciTech 7(1), Article 8.




9.1

Rita J. Majithiya, Pradip K. Ghosh, L. Umrethia,and Rayasa S.R. Murthy, Thermoreversible-mucoadhesive Gel for Nasal Delivery of Sumatriptan, AAPS PharmSciTech. 2006; 7(3): Article 67. 




9.2

Syamasri Gupta, S.P. Moulik. Biocompatible microemulsions and their prospective uses in drug delivery. J Pharmaceutical Sci 97: 22-45 (2007).




9.3

Mukesh Kumar,  Kamla Pathak, Ambikanandan Misra. Formulation and Characterization of Nanoemulsion-Based Drug Delivery System of Risperidone. Drug Development and Industrial Pharmacy/ 35: 387 – 395 (2009).




9.4

Meritxell Teixidó, Ernest Giralt. The role of peptides in blood-brain barrier nanotechnology Journal of Peptide Science 14: 163 – 173 (2007).




9.5

Wu H, Hu K, Jiang X. From nose to brain: understanding transport capacity and transport rate of drugs. Expert Opin Drug Deliv 5:1159-68 (2008).




9.6

Shyeilla V. Dhuria, Leah R. Hanson, William H. Frey II 1 Journal of Pharmaceutical Sciences

Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system Journal of Pharmaceutical Sciences Published Online: 21 Nov 2008






9.7

Majithiya RJ, Ghosh PK, Umrethia ML, Murthy RSR. Thermoreversible-mucoadhesive Gel for Nasal Delivery of Sumatriptan. AAPS PharmSciTech 2006; 7(3): Article 67. DOI:  10.1208/pt070367.




9.8

Mukesh Kumar‌, Ambikanandan Misra, A. K. Mishra‌, Pushpa Mishra‌, Kamla Pathak Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting. Journal of Drug Targeting 2008; 16: 806-814.




9.9

Sheetal Porecha, Tapan Shah, Viral Jogani, Sachin Naik, Ambikanandan Misra. Microemulsion based intranasal delivery system for treatment of insomnia. Drug Delivery 16(3): 128-134 (2009).




9.10

Amrish Kumar, Pankaj Sharma, Ashwani Chaturvedi, Durga Jaiswal, Meenakshi Bajpai, Mukesh Choudhary, Indranil Kumar Yadav, Hari Pratap Singh,Dinesh Chandra and D.A. Jain. Formulation Devleopment of Sertraline Hydrochloride Microemulsion for intranasal delivery. Int J Chemtech Res 1; 941-947 (2009)




9.11

Thomas M Barchet‌ & Mansoor M Amiji‌. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases. Expert Opinion on Drug Delivery 6; 211-225 (2009)




9.12

Mukesh Kumar, Kamla Pathak, Ambikanandan Misra. Formulation and Characterization of Nanoemulsion-Based Drug Delivery System of Risperidone. Drug Development and Industrial Pharmacy 35; 387 – 395 (2009).




9.13

Luthringer R, Djupesland PG, Sheldrake CD, Flint A, Boeijinga P, Danjou P, Demazières A, Hewson G. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device. J. Pharmacy and Pharmacology 61; 1219-1228 (2009).




9.14

Gitanjali Sharma, Anil Kumar Mishra, Pushpa Mishra and Ambikanandan Misra. Intranasal Cabergoline: Pharmacokinetic and Pharmacodynamic Studies. AAPS PharmSciTech 10; 1321-1330.


10

Babbar AK, Singh AK, Goel HC, Chauhan UP, Sharma RK. Evaluation of (99m) Tc-labeled photosan-3, a hematoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphy. Nuclear Medicine and Biology. (4) 419-426 (2000)




10.1

Gupta S, Mishra AK, Muralidhar K, Jain V. Improved targeting of photosensitizers by intratumoral administration of immunoconjugates. Technology in Cancer Research and Treatment 3 (3), 295-301, (2004)




10.2

J. Ali, S. Arora, A. Ahuja, A.K. Babbar, R.K. Sharma and R. K. Khar Formulation and development of floating capsules of celecoxib: In vitro and in vivo evaluation. The AAPS PharmSciTech. 2007; 8(4): Article 119, (2007)




10.3

Tushar K Vyas, A K Babbar, R K Sharma, Shashi Singh, Ambikanandan Misra. Intranasal Mucoadhesive Microemulsions of Clonazepam: Preliminary studies on Brain Targetting. J. Pharm. Sci. 95(3), 570-580, (2006)




10.4

Tushar K. Vyas, A. K. Babbar, R. K. Sharma, Shashi Singh, Ambikanandan Misra. Preliminary Brain Targeting Studies on Intranasal Mucoadhesive Microemulsions of Sumatriptan. AAPS PharmSciTech 7(1), Article 8. (http://www.aapspharmscitech.org), (2006)




10.5

Tushar K. Vyas, A.K. Babbar, R.K. Sharma, Ambikanandan Misra. Intranasal Mucoadhesive Microemulsions of Zolmitriptan: Preliminary Studies on Brain-targeting. J. Drug Target, 13(5), 317-326. (2005)




10.6

PJ Shah, VV Jogani, P Mishra, AK Mishra, T Bagchi, Misra AR. Role of 99mTc-mannitol and 99mTc-PEG in the assessment of paracellular integrity of cell monolayers. Nucl Med Commun. 28(8), 653-9 (2007)




10.7

Subbarayan M, Shetty SJ, Srivastava TS, Noronha OPD, Samuel AM. Evaluation studies of technetium-99 m-porphyrin(T 3, 4 BCPP) for tumor imaging. Journal of Porphyrins and Phthalocyanines, 5(12), 824 – 828 (2001)




10.8

Celentano L, Laccetti P, Liuzzi R, Mettivier G, Montesi MC, Autiero M Riccio P, Salvatore M. Preliminary Tests of a Prototype System for Optical and Radionuclide Imaging in Small Animals. IEEE Transactions on Nuclear Science 50 (5 II), 1693-1701 (2003)




10.9

Celentano L, Laccetti P, Liuzzi R, Mettivier G. Preliminary tests of a prototype system for optical and radionuclide imaging in small animals. IEEE Nuclear Science Symposium and Medical Imaging Conference (2002)




10.10

Castano AP, Demidov TN, Hamblin MR. Mechanism in photodynamic therapy: part three – photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagnosis and Photodynamic Therapy 2, 91-106 (2005)



SUMMARY OF CITATIONS OF 10 IMPORTANT ARTICLES (till March 2012)

Research Manuscript

Citations

Int J Pharm 243: 93-105 (2002)

151

Phytotherapy Research 19: 1-22 (2005)

142

J Pharm Sci 95(3): 570-580 (2006)

72

J Biotech 122(4), 494-510 (2006)

51

AAPS Journal. Oct 7, 6(3), e23 (2004)

46

AAPS Pharm Sci Tech 7(1), Article 8 (2006)

41

Ind J Med Res 80: 541-545 (1984)

39

J Controlled Release 105: 185-198 (2005)

36

Mol Cell Biochem 273, 209-223.(2005)

33

Mol Cell Biochem 273, 193-208 (2005)

33

TOTAL CITATIONS

644

Total citations of 10 best publication = 644
Average Citation Value = 64.4

Summary of Involvement in various Programs/ Project Activities and salient achievements therein (2001 till date)

I. Summary of Involvement in various Programmes / Project Activities and salient achievements therein



Project No.& PDC

Title of Project

Involvement

Status

Salient Achievement(s)

Subprogramme No. 2 of INMAS XI Five year Programme entitled, ‘Enhancing Troops Health Through Radiation Science Approach’ (Date of sanction 19th June 2009.

Development of devices, technologies, strategies and approaches for mitigation of NBC/ CBRN Emergencies. (Cost Rs. 12.95 crores).

Technical Programme Co-ordinator and

Project Leader of Sub-programme 2



Ongoing

  • Proof of concept (POC) for development of virtual simulation facility to strengthen CBRN emergency training has been finalised. Specification frozen. Tender action in progress

  • Basic layout of the facility for housing simulation facilities has been finalised

  • One month free trial version of the software DiGuy™ & Vega Prime™ for scenario simulation has been evaluated at INMAS

  • Basic design of Decon Ring has been finalised

  • Mobile Whole body counter (Protection Factor 2) shall be built on TATRA 8X8 vehicle for assessment of internal contamination in field during any nuclear/radiological emergencies. This include Mil grade AC System and MCA with HpGe/NaI(Tl) detectors. Basic design layout has been developed

  • A radiochemical analytical facility for estimation of nuclear fall out radionuclides in blood, serum and fecal samples is under development. This facility will include High Resolution Magnetic Sector Field Inductive Coupled Plasma Mass Spectrometer in clean room of class 10K for the medium through put screening of exposed victims. Specifications for the same has been finalised and tender action is in progress

  • Integrated Real-time Hospital Information system for management of CBRN Emergencies is being developed

  • Protocol for Decon Assay for evaluation of self usable decontamination formulation has been developed

  • Basic prototype of disposable ‘Contaminated human liquid waste management system (CHLWMS)’ is under development

  • Validation studies of self indicating radiation dosimeter card are in progress




Department of Science and Technology sponsored Indo-Bulgarian Collabarative Project No. INT/Bulgaria/B-57/05 of Indo-Bulgarian POC in S&T 2008-11; PDC: 31-08-2011

Studies on antioxidants against oxidative stress induced by drug and radiation

Principal Investigator

Ongoing

  • Free radical scavenging Studies on Herbal extracts and a compound isolated from a radioresistant bacterium Bacillus Species (INM-1) using Electron Paramagnetic Resonance Spectroscopic technique was conducted.

  • A fraction of bacterial extract denoted as IBG-21 was found to scavenging DPPH free radical at about 94%. This fraction was also having SOD like activity and capable enough to neutralize superoxide free radicals in vitro as well as in vivo models

  • Identification of the bioactive entities of this fraction is in progress. Preliminary observation indicated the presence of a quinone glucoside derivative

  • EPR studies on ‘IBG’ series of three fractions i.e., IBG-21, IBG-RA-22, IBG-RA-26 were conducted. Firstly, affect of different pH values on radical formation in IBG-RA-22 solution revealing indication towards cation radical formation (semiquinone) with increasing pH. EPR based studies revealed IC50 = 27.7mM (DPPH radical scavenging)

  • A Workshop will be held during May 2012 in Bulgaria to review the progress

INMAS Task Project No. TC/2519/INM-01/2008; PDC: 22-07-2010

Awareness Generation and development of training modules for medical management of NBC eventualities

Principal Investigator

Closed

  • Two booklet entitled ‘‘Demystifying Chkunguniya’ and ‘Demystifying H1N1 Flu (Swine Flu)’ compiled and published

  • ICT based awareness generation material on CBRN Preparedness and Mock exercises collated and published

  • Books on ‘Chemical (Industrial) Disaster Management’ 2009 & 2010 and ‘Chemical (Industrial) Mock Exercises: Good Practices and Lessons Learnt’ were compiled and published

  • Training need analysis based training modules developed

INMAS Task Project No. TC/2519/INM-02/2008;PDC: May 2010

Upgradation of Whole Body Counter

Co-investigator

Ongoing

  • NaI(Tl) detectors have been checked for functionality

  • Action for procurement of required components is in progress

RD-P1-2002/DIP-233; PDC: 16-7-2007

Two sub-projects awarded to RRL (Jammu) and IHBT (Palampur).

IHBT-INMAS Charak (GAP-0048) (Sub project of DIP 233)

RRL Jammu-INMAS Charak (Subproject of DIP-233)



Development of a herbal formulation against lethal radiation doses for human application

Isolation and characterization of bioactive molecules from genus Hippophae for radioprotective efficacy


Isolation and fractionation of radioprotective molecules from Indian Podophyllum



Co-investigator and HoD


Completed



  • In vitro, in vivo and ex vivo screening of radioprotective efficacy of Podophyllum hexandrum, Hippophae rhamnoides and Rhodiola imbricata was carried out

  • Two promising lead fractions from Podophyllum hexandrum and one each from Hippophae rhamnoides and Rhodiola imbricata were identified

  • Aryl-tetralin lignans (Podophyllum hexandrum) and flavonoids from Hippophae rhamnoides and phenylpropanoids from Rhodiola imbricata were identified as active constituents in the lead fractions

  • Mechanistic studies on DNA repair, Heme oxygenase-I, Pro-antioxidant biphasic mechanism, mitochondrial oxidative stress, p53 knock out model, apoptosis induction and regulated mechanism were carried out

  • In silico modelling to identify the structural and quantitative characterstics of aryl-tetralin lignans was carried out

  • Neurobehavioral studies on Zingiber officinales and Mentha piperita was carried out using Conditioned Taste Aversion study model

  • Two fractions (Flavonoid rich and poor fractions) of Hippophae rhamnoides were screened for radiation protection

  • A novel triglyceride derivative was identified in Hippophae berries extract

  • Six fractionated extracts received from RRL Jammu were screened for radiation protection

  • A novel galactoside of quercetin was identified in hydro-alcoholic fractioned extract

  • An endophyte Trametes hirsuta was isolated from the rhizome of P. hexandrum and its independent culture was established producing various aryl-tetralin lignans

TC/2519/INM-12/2005; PDC: 20-5-2007

Study of stem cell proliferation / Adhesive & differentiation potential

Head of Division of Radiopharma-ceuticals

Completed

(RD-P1-2001/INM-294); PDC : 20-5-2005

Development of MR and Nuclear Medicine Techniques & Specific Radiopharmaceuticals for evaluation of structural and functional change due to radiation exposure

Principal Investigator and Head, Division of Radiopharma-ceuticals

Completed

  • Innnovative bifunctional chelating agents, radiopharmaceuticals, novel drug delivery systems and magentopharmaceuticals developed

  • Pharmacoscintigraphic technique for evaluation of drugs and drug delivery systems established

Department of Science and Technology –sponsored Indo-Italian Collabarative Project with Prof. Gian Battista Parigi, CICOPS- University of Pavia,Pavia (Project MH-9 of Indo-Italian POC in S&T 2002-2004)

Infection Scintigraphy with special reference to Tuberculosis

Principal Investigator and Head, Division of Radiopharma-ceuticals

Closed

  • Infection scintigraphic studies initiated

TC/2519-INM-02/2002; PDC 9-11- 2004

Knowledge management for physicochemical decontamination of radionuclides and improvement in skills / preparedness for management of radiation disasters

Co-investigator & Head, Division of Radiopharma-ceuticals

Completed

  • SHUDHIKA- a skin decontamination kit and protective clothings for QRMT developed. Technologies transferred to two firms

  • Value additions to these product is currently on- going to design Mark II

TC/2519-INM-03/2001; PDC: 11-11-2004

Basic studies on radioactivity removal from natural water resources by using complexation – adsorption agents

Co-investigator

Completed

  • Utility of natural gums and raisins for removal of radioactivity from natural water resources demonstrated

(RD-P1-2000/INM-292); PDC: 24-07-2003

To develop new and evaluate existing internal decorporation technique for fission produced radionuclides

Head, Division of Radiopharma-ceuticals

Completed

  • Development of innovative decorporating agents initiated



II. Functional responsibilities handled by me in above-mentioned programmes and activities include:


Yüklə 1,05 Mb.

Dostları ilə paylaş:
1   ...   6   7   8   9   10   11   12   13   ...   17




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©muhaz.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin